“Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis” (2026) Experimental and Theoretical NANOTECHNOLOGY, 10(3), pp. 1449–1468. doi:10.56053/10.3.1449.